HALO - Halozyme Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts99910
Avg. Estimate-0.12-0.14-0.36-0.43
Low Estimate-0.19-0.18-0.43-0.88
High Estimate-0.05-0.09-0.230.5
Year Ago EPS-0.19-0.01-0.56-0.36
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts7789
Avg. Estimate57.39M54.12M207.67M210.67M
Low Estimate46.5M46M204.61M133M
High Estimate68M64.3M211.2M274.5M
Year Ago SalesN/A60.23M151.86M207.67M
Sales Growth (year/est)N/A-10.10%36.70%1.40%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.23-0.030.01-0.14
EPS Actual-0.19-0.010.01-0.1
Difference0.040.0200.04
Surprise %17.40%66.70%0.00%28.60%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.12-0.14-0.36-0.43
7 Days Ago-0.12-0.14-0.36-0.43
30 Days Ago-0.12-0.14-0.36-0.43
60 Days Ago-0.12-0.14-0.36-0.43
90 Days Ago-0.14-0.14-0.42-0.43
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesHALOIndustrySectorS&P 500
Current Qtr.36.80%N/AN/A-0.02
Next Qtr.-1,300.00%N/AN/A0.07
Current Year35.70%N/AN/A-0.02
Next Year-19.40%N/AN/A0.14
Next 5 Years (per annum)55.00%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A